Families caring for children and adolescents with rare disease: a health economic evaluation of face-to-face and online psychosocial support intervention of the randomized controlled CARE-FAM-NET study.
Online and in-person support for families of children with rare diseases were similarly cost-effective, though cost differences weren't statistically significant.
This randomized controlled trial economic evaluation examined families caring for children and adolescents with rare disease: a health economic evaluation of face-to-face and online psychosocial support intervention of the randomized controlled care-fam-net study. The PubMed abstract reports in the care-fam-net randomized study, face-to-face and web-based support had favorable cost-effectiveness probabilities, but cost and quality-adjusted-life-year differences were not statistically significant.
What the study was
- Study design
- Randomized controlled trial economic evaluation
- Population
- Parents caring for children or adolescents with rare diseases
- Category
- Public Health
- Maturity
- Validated
- Journal
- Health economics review
Why it surfaced
Score reflects the randomized controlled trial economic evaluation design and relevance to Rare diseases with high unmet need; classification is limited to PubMed title, metadata, and abstract evidence.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.